Clinical Trial Update: Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the combination of Everolimus and Tacrolimus for regression of left ventricular hypertrophy in renal transplant patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Hypertrophy
• Renal Transplant Recipient

Drugs mentioned

• Everolimus (everolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Edoardo Melilli | Conditions: Hypertrophy, Left Ventricular | Phase 4 | Status: COMPLETED